Novo Integrated Sciences, Inc. Share Price
Equities
NVOS
US67011T3005
Healthcare Facilities & Services
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.543 USD | +4.62% | +6.99% | -33.07% |
Sales 2022 | 11.74M 935M | Sales 2023 | 12.57M 1B | Capitalization | 21.96M 1.75B |
---|---|---|---|---|---|
Net income 2022 | -32M -2.55B | Net income 2023 | -13M -1.04B | EV / Sales 2022 | 5.36 x |
Net Debt 2022 | 11.3M 900M | Net Debt 2023 | 4.06M 323M | EV / Sales 2023 | 2.07 x |
P/E ratio 2022 |
-1.48
x | P/E ratio 2023 |
-1.08
x | Employees | 179 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.18% |
1 day | +4.62% | ||
1 week | +6.99% | ||
Current month | +12.79% | ||
1 month | +13.56% | ||
3 months | -30.68% | ||
6 months | -78.83% | ||
Current year | -33.07% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 17/10/18 | |
Vivek Sethi
DFI | Director of Finance/CFO | 38 | 06/07/23 |
Robert Oliva
PSD | President | 60 | 02-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Pope
BRD | Director/Board Member | 43 | 25/01/21 |
Chief Operating Officer | 65 | 12/08/14 | |
Sarfaraz Ali
BRD | Director/Board Member | 42 | 29/06/22 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.5376 | +3.58% | 124 124 |
26/04/24 | 0.519 | -1.26% | 470,838 |
25/04/24 | 0.5256 | +0.11% | 521,135 |
24/04/24 | 0.525 | +1.94% | 536,411 |
23/04/24 | 0.515 | +0.27% | 1,480,471 |
Delayed Quote Nasdaq, April 29, 2024 at 04:49 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.07% | 9.89M | |
-14.37% | 84.68B | |
+14.82% | 81.12B | |
+11.62% | 29.59B | |
-9.18% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.13% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- NVOS Stock